Videos and webinars

  1. Fluid Management Solutions 5/5/2026

    Reliable fluid handling underpins progress in biopharma. Explore how precision, scalability, and trust in critical systems reduce risk, support growth, and give teams confidence.

  2. Introducing CPC Biotech 4/30/2026

    Explore how the integration of global expertise in fluid management and expanded manufacturing capacity is driving innovation across the rapidly growing cell and gene therapy markets.

  3. Expanded Series Of Connectors For Even More Versatility 4/30/2026

    Discover how high-temp PPSU sterile connectors offer pH resistance and autoclave compatibility, providing the durability and versatility required for modern downstream bioprocessing workflows.

  4. Fostering Closed-System Innovation For Flexibility And Scalability 4/7/2026

    Transitioning from lab to large-scale manufacturing requires robust, reproducible processes. Explore innovative technologies that provide the flexibility needed to scale cell and gene therapies.

  5. How CDMOs Are Evolving To Serve A Diverse And Emerging CGT Market 1/12/2026

    This segment of Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen, explored how the CDMO landscape is adapting to support the growing diversity of CGT modalities, particularly for small and mid-sized developers that often lack in-house capabilities.

  6. Digital Strategies Driving Efficiency And Throughput In CGT Manufacturing 1/12/2026

    This segment of Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen focused on how digital and operational innovation is reshaping efficiency, cost control, and capacity planning in CGT manufacturing.

  7. Capacity, Risk, And The Role Of Digital Innovation 1/12/2026

    This portion of Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen focused on how developers can assess whether a CDMO is truly equipped to support multimodal programs without introducing capacity bottlenecks, quality drift, or compliance risk. Our experts emphasized that credible CDMOs demonstrate both process maturity through documented, consistently followed planning practices and digital maturity with robust capacity models and simulation tools rather than ad hoc spreadsheets.

  8. Scaling Quality And Managing Cost Pressures Across CGTs 1/12/2026

    During Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen examined how CGT developers can scale quality organizations without creating unsustainable overhead, while also addressing the distinct cost pressures of cell versus gene therapy manufacturing.

  9. Workforce Readiness And A Final Checklist For Multi-Modal CDMO Selection 1/12/2026

    The closing segment of Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen emphasized that true multi-modal readiness depends as much on people and governance as on facilities and technology. Our experts stressed the importance of a deeply trained, modality-specific workforce, shaped by practical factors such as geographic access to skilled aseptic operators, alongside robust training strategies to build talent where gaps exist.

  10. Choosing The Right CDMO In A Multi-Modal CGT Landscape 1/12/2026

    Our first segment of Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen set the stage for how cell and gene therapy developers are rethinking outsourcing as pipelines expand beyond single modalities, weighing the tradeoffs between using one multimodal CDMO versus multiple specialized partners.